ArticleLeukemia2026

In vivo expression of CD3/CD19 bispecific T-cell engager and α-PD-L1-Fc enables effective and durable immunotherapy for CD19

Yueyao Yang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.